查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1568085

DNA 微阵列的全球市场

DNA Microarrays
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 234 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球 DNA 微阵列市场预计将达到 35 亿美元

全球 DNA 微阵列市场预计 2023 年为 21 亿美元，预计到 2030 年将达到 35 亿美元，2023 年至 2030 年复合年增长率为 7.4%。寡核苷酸微阵列是本报告分析的细分市场之一，预计复合年增长率为 7.3%，到分析期结束时将达到 26 亿美元。在分析期间，互补微阵列领域的复合年增长率预计为 8.2%。

美国市场预估为5.622亿美元，中国预期复合年增长率为7.2%

预计 2023 年美国DNA 微阵列市场规模将达 5.622 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达5.631亿美元，2023年至2030年复合年增长率为7.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.8% 和 6.3%。在欧洲，德国预计复合年增长率为 5.9%。

全球 DNA 微阵列市场 – 主要趋势与驱动因素总结

DNA 微阵列如何彻底改变基因组研究？

DNA 微阵列在基因组学中发挥越来越重要的作用，使研究人员能够同时分析数千个基因的基因表现模式和遗传变异。这些设备由附着在固体表面上的 DNA 探针微观点组成，可在疾病诊断、药物开发和个人化医疗等各种应用中对基因序列进行高通量分析。在癌症研究中，它用于识别突变和基因表现，从而深入了解肿瘤分类和潜在的治疗途径。此外，这项技术已成为遗传疾病研究的重要工具，帮助科学家了解基因与环境的相互作用和复杂的疾病机制。随着精准医疗需求的不断增长，DNA 微阵列正成为基因组研究的基石，促进更快、更准确和更大规模的遗传分析。

哪些技术进步正在推动 DNA 微阵列的发展？

技术创新极大地影响了 DNA 微阵列的发展和效率，使其更加准确且可扩展，适合各种应用。微阵列製造技术的进步提高了这些设备的分辨率和灵敏度，使研究人员能够更准确地分析更小的样品。标记和检测方法的创新，例如基于萤光的检测，提高了检测低丰度基因表现的能力。此外，生物资讯学工具的整合促进了 DNA 微阵列生成的大型资料集的管理、解释和视觉化，使研究人员能够从复杂的资料中获得有意义的生物学见解。此外，多重技术的使用可以同时检测多种生物标记物，使 DNA 微阵列成为诊断和药物开发的宝贵工具。随着这些技术的不断发展，DNA 微阵列以经济高效的方式提供高分辨率遗传资料的能力进一步支持其在不同研究领域的采用。

消费者和产业行为如何影响 DNA 微阵列的需求？

消费者和行业行为，特别是对个人化医疗和标靶治疗的日益关注，正在推动临床和研究环境中对 DNA 微阵列的需求。患者越来越多地寻求适合其遗传特征的治疗方法，这增加了对基因组工具的需求，以识别遗传倾向并指导治疗决策。在製药业，DNA微阵列广泛应用于药物发现和开发，特别是在识别药物标靶以及评估药物疗效和安全性方面。农业生物技术也采用 DNA 微阵列来增强作物性状、优化育种计画和粮食安全。此外，直接面向消费者的基因检测的兴起提高了人们对个人遗传健康的认识，并增加了对基因研究和诊断的兴趣。消费者和产业行为的这些变化正在推动 DNA 微阵列的采用，它为基因组学主导的决策提供了关键资料。

推动DNA微阵列市场成长的因素有哪些？

DNA 微阵列市场的成长是由与技术进步、扩大最终用途和不断变化的消费行为相关的几个因素所推动的。主要驱动力之一是个人化医疗中越来越多地采用 DNA 微阵列，这种医疗利用遗传讯息来开发客製化的治疗方法和治疗方法。微阵列分辨率和灵敏度的提高以及生物资讯学的整合等技术创新使该技术更易于大规模基因组研究使用和高效，从而进一步推动市场发展。随着癌症研究、药物发现和农业生物技术等领域对详细遗传分析的需求的增加，这些领域的最终用途正在扩大。此外，直接面向消费者的基因检测服务的兴起增加了消费者对基因组学的兴趣，推动了临床和商业应用对 DNA 微阵列的需求。这些综合因素，加上基因组学研究投资的增加，正在推动 DNA 微阵列技术在全球的快速成长和采用。

受访企业范例（共45家）

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Arrayjet
  • BioCat GmbH
  • Bio-Rad Laboratories, Inc.
  • DNA Chip Research, Inc.
  • Eurofins Genomics Germany GmbH
  • evonetix
  • Illumina, Inc.
  • LC Sciences LLC

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP24449

Global DNA Microarrays Market to Reach US$3.5 Billion by 2030

The global market for DNA Microarrays estimated at US$2.1 Billion in the year 2023, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Oligonucleotide Microarrays, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.6 Billion by the end of the analysis period. Growth in the Complementary Microarrays segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$562.2 Million While China is Forecast to Grow at 7.2% CAGR

The DNA Microarrays market in the U.S. is estimated at US$562.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$563.1 Million by the year 2030 trailing a CAGR of 7.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR.

Global DNA Microarrays Market - Key Trends & Drivers Summarized

How Are DNA Microarrays Revolutionizing Genomic Research?

DNA microarrays are playing an increasingly pivotal role in genomics, enabling researchers to analyze gene expression patterns and genetic variations across thousands of genes simultaneously. These devices consist of microscopic spots of DNA probes attached to a solid surface, allowing for the high-throughput analysis of gene sequences in various applications, including disease diagnostics, drug development, and personalized medicine. In cancer research, DNA microarrays are used to identify mutations and gene expression profiles, providing insights into tumor classification and potential treatment pathways. Furthermore, the technology has become an essential tool in the study of genetic disorders, helping scientists understand gene-environment interactions and complex disease mechanisms. As the demand for precision medicine continues to rise, DNA microarrays are becoming a cornerstone in genomics research, facilitating faster, more accurate, and large-scale genetic analysis.

What Technological Advancements Are Driving the Evolution of DNA Microarrays?

Technological innovations are significantly shaping the development and efficiency of DNA microarrays, making them more precise and scalable for a variety of applications. Advancements in microarray fabrication techniques have improved the resolution and sensitivity of these devices, allowing researchers to analyze smaller samples with greater accuracy. Innovations in labeling and detection methods, such as fluorescence-based assays, have enhanced the ability to detect even low-abundance gene expressions. Moreover, the integration of bioinformatics tools has made it easier to manage, interpret, and visualize large datasets generated by DNA microarrays, enabling researchers to derive meaningful biological insights from complex data. Additionally, the use of multiplexing technologies has allowed for the simultaneous detection of multiple biomarkers, making DNA microarrays an invaluable tool for diagnostics and drug development. As these technologies continue to evolve, the capability of DNA microarrays to provide high-resolution genetic data in a cost-effective and time-efficient manner is further driving their adoption across diverse research fields.

How Is Consumer and Industry Behavior Influencing the Demand for DNA Microarrays?

Consumer and industry behavior, particularly the increasing focus on personalized medicine and targeted therapies, is driving the demand for DNA microarrays in clinical and research settings. Patients are increasingly seeking treatments tailored to their genetic profiles, which has led to greater demand for genomic tools that can identify genetic predispositions and guide therapeutic decisions. In the pharmaceutical industry, DNA microarrays are being used extensively in drug discovery and development, particularly in the identification of drug targets and the assessment of drug efficacy and safety. The agricultural biotechnology sector is also adopting DNA microarrays to enhance crop traits, optimize breeding programs, and ensure food security. Additionally, the rise of direct-to-consumer genetic testing has made individuals more aware of their genetic health, spurring interest in genetic research and diagnostics. This shift in consumer and industry behavior is significantly boosting the adoption of DNA microarrays, as they provide critical data for genomics-driven decision-making.

What Factors Are Driving Growth in the DNA Microarrays Market?

The growth in the DNA microarrays market is driven by several factors related to technological advancements, expanding end-use applications, and evolving consumer behavior. One of the primary drivers is the increasing adoption of DNA microarrays in personalized medicine, where genetic information is used to develop customized treatments and therapies. Technological innovations, such as improvements in microarray resolution, sensitivity, and bioinformatics integration, are further propelling the market by making the technology more accessible and efficient for large-scale genomic studies. End-use applications in cancer research, drug discovery, and agricultural biotechnology are expanding as the need for detailed genetic analysis grows across these sectors. Additionally, the growing interest in consumer genomics, driven by the rise of direct-to-consumer genetic testing services, is boosting the demand for DNA microarrays in both clinical and commercial applications. These combined factors, along with increasing investment in genomics research, are driving the rapid growth and adoption of DNA microarray technology worldwide.

Select Competitors (Total 45 Featured) -

  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Arrayjet
  • BioCat GmbH
  • Bio-Rad Laboratories, Inc.
  • DNA Chip Research, Inc.
  • Eurofins Genomics Germany GmbH
  • evonetix
  • Illumina, Inc.
  • LC Sciences LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • DNA Microarrays - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Personalized Medicine and Genomic Research Spurs Growth in DNA Microarrays Market
    • Technological Advancements in High-Throughput Screening Strengthen Business Case for DNA Microarrays in Precision Medicine
    • Increasing Adoption of DNA Microarrays in Cancer Research Expands Market for Advanced Genetic Testing
    • Growing Use of DNA Microarrays in Drug Discovery and Development Drives Demand in Pharmaceutical Sector
    • Expansion of Genomic Studies for Complex Diseases Propels Adoption of DNA Microarray Technology
    • Rising Interest in Gene Expression Profiling and Biomarker Discovery Creates New Opportunities in Research
    • Advancements in Bioinformatics Tools and Data Analysis Solutions Strengthen the Utility of DNA Microarrays
    • Increasing Use of DNA Microarrays in Agriculture and Animal Genomics Expands Non-Clinical Applications
    • Growing Focus on Early Disease Detection and Diagnostics Drives Demand for DNA Microarray-Based Tests
    • Technological Integration of Next-Generation Sequencing with DNA Microarrays Enhances Performance and Flexibility
    • Rising Use of DNA Microarrays in Pathogen Detection and Infection Monitoring Expands Healthcare Applications
    • Expansion of Consumer Genomics and Direct-to-Consumer Genetic Testing Fuels Growth in DNA Microarrays Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World DNA Microarrays Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oligonucleotide Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oligonucleotide Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Oligonucleotide Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Complementary Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Complementary Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Complementary Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Microarray Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Microarray Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Microarray Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institute End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institute End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Academic & Research Institute End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Gene Expression Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Gene Expression Analysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Gene Expression Analysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Genotyping Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Genotyping Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • JAPAN
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • CHINA
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • EUROPE
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for DNA Microarrays by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • FRANCE
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • GERMANY
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • DNA Microarrays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for DNA Microarrays by Microarray Type - Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for DNA Microarrays by Microarray Type - Percentage Breakdown of Value Sales for Oligonucleotide Microarrays, Complementary Microarrays and Other Microarray Types for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for DNA Microarrays by End-Use - Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for DNA Microarrays by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics End-Use, Other End-Uses, Academic & Research Institute End-Use, Pharma & Biotech Companies End-Use and Diagnostic Centers End-Use for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for DNA Microarrays by Application - Gene Expression Analysis Application, Genotyping Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for DNA Microarrays by Application - Percentage Breakdown of Value Sales for Gene Expression Analysis Application, Genotyping Application and Other Applications for the Years 2014, 2024 & 2030

IV. COMPETITION